Antidepressant adherence among outpatients with major depressive disorder

Major Depressive Disorder (MDD) is a global mental health concern, with treatment often involving antidepressant (AD) medications. However, adherence to these medications remains a significant challenge. This study aims to investigate the factors influencing medication adherence among individuals wi...

Full description

Bibliographic Details
Published in:Pharmacia
Main Author: Yassen A.O.; Mahmud N.M.; Bilal A.D.; Wahab M.S.A.
Format: Article
Language:English
Published: Pensoft Publishers 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196545035&doi=10.3897%2fPHARMACIA.71.E123345&partnerID=40&md5=1a1ef844e2b39819506f0cf20a160cab
id 2-s2.0-85196545035
spelling 2-s2.0-85196545035
Yassen A.O.; Mahmud N.M.; Bilal A.D.; Wahab M.S.A.
Antidepressant adherence among outpatients with major depressive disorder
2024
Pharmacia
71

10.3897/PHARMACIA.71.E123345
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196545035&doi=10.3897%2fPHARMACIA.71.E123345&partnerID=40&md5=1a1ef844e2b39819506f0cf20a160cab
Major Depressive Disorder (MDD) is a global mental health concern, with treatment often involving antidepressant (AD) medications. However, adherence to these medications remains a significant challenge. This study aims to investigate the factors influencing medication adherence among individuals with MDD in Erbil, Iraq. This study was conducted at Erbil Psychiatric Hospital, a leading mental healthcare facility in Erbil city. Participants aged 18 to 65, diagnosed with MDD as per the DSM-5 criteria, were treated with antidepressants. The recruitment of 106 participants was facilitated by their treating psychiatrists at the hospital. Data analysis was conducted using SPSS version 22, standard for social science research. Out of the 106 participants, 64.2% were females, and 35.8% were males. The largest age group was 35–45, comprising 33% of the sample. A vast majority (99.1%) were under regular follow-up, with only 0.9% experiencing relapse. The primary antidepressant used was selective serotonin reuptake inhibitors (SSRIs) (72.6%). Most participants (61.3%) reported very high medication adherence. The notable barriers included treatment duration (13.4%), forgetting to take antidepressants (11.9%), frequent medication refills (17.9%), cultural and religious beliefs (19.3%), stigma (19.3%), travelling issues (42.9%), and lack of hospitals and clinics (30.8%). Healthcare facilitators such as effectiveness of antidepressants (27.5%), patient-provider relationship such as trusting healthcare providers (50.7%), and reminders such as keeping pills in visible places (65.9%) were prominent facilitators aiding adherence. Future research should focus on culturally tailored interventions and collaborative efforts among stakeholders. By addressing socio-cultural nuances and enhancing mental health support, more effective strategies can be developed to tackle medication adherence challenges in Erbil’s unique context. Copyright Yassen AO et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Pensoft Publishers
4280296
English
Article
All Open Access; Gold Open Access
author Yassen A.O.; Mahmud N.M.; Bilal A.D.; Wahab M.S.A.
spellingShingle Yassen A.O.; Mahmud N.M.; Bilal A.D.; Wahab M.S.A.
Antidepressant adherence among outpatients with major depressive disorder
author_facet Yassen A.O.; Mahmud N.M.; Bilal A.D.; Wahab M.S.A.
author_sort Yassen A.O.; Mahmud N.M.; Bilal A.D.; Wahab M.S.A.
title Antidepressant adherence among outpatients with major depressive disorder
title_short Antidepressant adherence among outpatients with major depressive disorder
title_full Antidepressant adherence among outpatients with major depressive disorder
title_fullStr Antidepressant adherence among outpatients with major depressive disorder
title_full_unstemmed Antidepressant adherence among outpatients with major depressive disorder
title_sort Antidepressant adherence among outpatients with major depressive disorder
publishDate 2024
container_title Pharmacia
container_volume 71
container_issue
doi_str_mv 10.3897/PHARMACIA.71.E123345
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196545035&doi=10.3897%2fPHARMACIA.71.E123345&partnerID=40&md5=1a1ef844e2b39819506f0cf20a160cab
description Major Depressive Disorder (MDD) is a global mental health concern, with treatment often involving antidepressant (AD) medications. However, adherence to these medications remains a significant challenge. This study aims to investigate the factors influencing medication adherence among individuals with MDD in Erbil, Iraq. This study was conducted at Erbil Psychiatric Hospital, a leading mental healthcare facility in Erbil city. Participants aged 18 to 65, diagnosed with MDD as per the DSM-5 criteria, were treated with antidepressants. The recruitment of 106 participants was facilitated by their treating psychiatrists at the hospital. Data analysis was conducted using SPSS version 22, standard for social science research. Out of the 106 participants, 64.2% were females, and 35.8% were males. The largest age group was 35–45, comprising 33% of the sample. A vast majority (99.1%) were under regular follow-up, with only 0.9% experiencing relapse. The primary antidepressant used was selective serotonin reuptake inhibitors (SSRIs) (72.6%). Most participants (61.3%) reported very high medication adherence. The notable barriers included treatment duration (13.4%), forgetting to take antidepressants (11.9%), frequent medication refills (17.9%), cultural and religious beliefs (19.3%), stigma (19.3%), travelling issues (42.9%), and lack of hospitals and clinics (30.8%). Healthcare facilitators such as effectiveness of antidepressants (27.5%), patient-provider relationship such as trusting healthcare providers (50.7%), and reminders such as keeping pills in visible places (65.9%) were prominent facilitators aiding adherence. Future research should focus on culturally tailored interventions and collaborative efforts among stakeholders. By addressing socio-cultural nuances and enhancing mental health support, more effective strategies can be developed to tackle medication adherence challenges in Erbil’s unique context. Copyright Yassen AO et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
publisher Pensoft Publishers
issn 4280296
language English
format Article
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1809678012592947200